2-((2S,5R,8S,11S)-8-(4-Aminobutyl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid 2,2,2-trifluoroacetic acid 2-((2S,5R,8S,11S)-8-(4-氨基丁基)-5-苄基-11-(3-胍基丙基)-3,6,9,12,15-戊氧基-1,4,7,10,13-五氮杂环十五烷-2-基)乙酸 2,2,2-三氟乙酸盐

CAS 500577-51-5 MFCD20488083

化学结构图

500577-51-5
SMILES:

别名和识别编码

Chemical Name Translation2-((2S,5R,8S,11S)-8-(4-氨基丁基)-5-苄基-11-(3-胍基丙基)-3,6,9,12,15-戊氧基-1,4,7,10,13-五氮杂环十五烷-2-基)乙酸 2,2,2-三氟乙酸盐
Chemical Name2-((2S,5R,8S,11S)-8-(4-Aminobutyl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid 2,2,2-trifluoroacetic acid
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Lopez-Rodriguez V, et al. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Nucl Med Biol. 2015 Feb;42(2):109-14.
  • [1]. Simecek J, et al. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). Mol Pharm. 2014 May 5;11(5):1687-95.
  • [1]. Simecek J, et al. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). Mol Pharm. 2014 May 5;11(5):1687-95.
  • [2]. Lopez-Rodriguez V, et al. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Nucl Med Biol. 2015 Feb;42(2):109-14.

系列性分类

  1. Medical Research Areas
  2. Cytosketetal Signaling
  3. Integrin  (整合素)

相关产品推荐